Loading…
Mobile-health Network Solutions is projected to decline to $1.84 by 2027, a 0% move from its current price of $1.85. MNDR is currently trading below its 50-day average (a bearish sign). Technical indicators currently lean sell.
A data-driven summary — not financial advice. See the full breakdown below.
Live market data via Yahoo Finance · updated 8/4/2026
| Period | Min | Prediction | Max | Change |
|---|---|---|---|---|
| Aug 5 | $1.71 | $1.85 | $2.00 | +0.04% |
| Aug 6 | $1.66 | $1.85 | $2.06 | +0.08% |
| Aug 7 | $1.62 | $1.85 | $2.11 | +0.13% |
| Aug 8 | $1.59 | $1.85 | $2.16 | +0.17% |
| Aug 9 | $1.56 | $1.85 | $2.20 | +0.21% |
| Aug 10 | $1.54 | $1.85 | $2.24 | +0.25% |
| Aug 11 | $1.52 | $1.86 | $2.27 | +0.30% |
| Period | Min | Prediction | Max | Change |
|---|---|---|---|---|
| Week 1 | $1.52 | $1.86 | $2.27 | +0.30% |
| Week 2 | $1.40 | $1.86 | $2.48 | +0.60% |
| Week 3 | $1.31 | $1.87 | $2.65 | +0.89% |
| Week 4 | $1.25 | $1.87 | $2.81 | +1.20% |
| Week 5 | $1.19 | $1.88 | $2.95 | +1.50% |
| Week 6 | $1.15 | $1.88 | $3.09 | +1.80% |
| Week 7 | $1.11 | $1.89 | $3.23 | +2.10% |
Short-term targets derived from the forecast trend and recent volatility. Highly uncertain — not financial advice.
Mobile-health Network Solutions is an investment holding company that provides telehealth solutions primarily in Singapore. It operates in two segments: Telemedicine and Other Services and Sale of Medicine and Medical Devices. It offers MaNaDr platform, a 360-degree healthcare ecosystem, which connects users and service providers through the range of healthcare services and product offerings that can be accessed through the mobile application and website, as well as Internet search engines.
The company also provides a suite of medical-related and other services, including teleconsultations and health check-up services, vaccinations, skin and aesthetics services, and other services. In addition, it offers healthcare and wellness products through its online e-commerce platform; wholesale distribution of pharmaceutical products to clinics through MaNaPharma platform; and MaNaCare, a platform that provides a range of corporate healthcare and wellness services, including GP, specialist and allied healthcare panel services, tele-consultation services, in-person clinics, on-site health screening, and online marketplace, as well as wellness programs to corporate customers.
Further, the company develops IT systems on mobile phone and web portals; operates pharmacies, clinics, and drug stores; and offers beauty and other personal care services, as well as other general medical services. Additionally, it offers health supplements, skincare, nutrition products and medical devices wellness, personal care; health screening packages; and online services such as medical screenings and procedures, such as serology and swab tests. The company was founded in 2009 and is headquartered in Singapore.
MNDR is a healthcare asset listed with a current price of $1.88 and a market capitalization of $2.25M. It is ranked 5428.
The forecast provides a year-by-year outlook where the average price for 2026 is $1.88 and the subsequent years show a mixed path, with 2027 at $1.88, 2028 at $1.71, 2029 at $1.77, 2030 at $1.48, 2031 at $1.51, 2032 at $1.93, 2033 at $2.20, 2034 at $2.61, and 2035 at $2.34.
In the longer horizon, 2040 shows an average price of $3.36 and 2050 an average price of $4.70, with ROI values of 78.5 and 149.8 respectively. The forecast also notes sentiment as bullish for 2034, 2035, 2040, and 2050, and bearish for 2030 and 2031.
A major floor 74.6% below — a decisive break under it would weaken the trend.
The nearest floor, 21.6% below — buyers have tended to step in here.
The nearest ceiling, 97.8% above — a clean break opens room to run.
A major ceiling 174.2% above — clearing it would confirm fresh momentum.
Key MNDR support and resistance from recent price action — levels where the trend has historically paused or reversed. Percentages are the distance from the current price.
A snapshot of MNDR market posture derived from its technical indicators and recent volatility. Higher trend and alignment lean bullish; higher risk means larger swings.
Technical Analysis
Indicators computed on daily closing prices.
| Period | SMA | Action | EMA | Action |
|---|---|---|---|---|
| MA 5 | $1.71 | Buy | $1.86 | Sell |
| MA 10 | $2.23 | Sell | $2.13 | Sell |
| MA 20 | $2.76 | Sell | $2.29 | Sell |
| MA 50 | $1.73 | Buy | $1.96 | Sell |
| MA 100 | $1.33 | Buy | $1.70 | Buy |
| MA 200 | $1.47 | Buy | $3.74 | Sell |
| Name | Value | Action |
|---|---|---|
| RSI (14) | 42.80 | Neutral |
| Stoch RSI (14) | 24.57 | Neutral |
| CCI (20) | -98.28 | Neutral |
| Williams %R (14) | -76.94 | Info |
| MACD (12,26,9) | -0.23 | Sell |
| ROC (12) | -42.51 | Sell |
| Bollinger %B (20,2) | 0.17 | Neutral |
| Stochastic %K (14) | 23.06 | Neutral |
| TRIX (15) | 1.54 | Buy |
| Awesome (5,34) | -0.48 | Sell |
| Ultimate (7,14,28) | 27.65 | Buy |
| Momentum (10) | -1.33 | Sell |
| Aroon Osc (25) | 8.00 | Buy |
| Hull MA (9) | 1.41 | Buy |
| ADX (14) | 33.93 | Sell |
| ATR (14) | 0.19 | Info |
The 30-day technical picture is bearish, with RSI14 at 30. The price is trading below the SMA50 of $3.54 and the SMA200 of $7.08, indicating weakness. The 30-day price range spans $1.14 to $3.11, with a defined support at $1.45 and resistance at $3.66. The asset shows an annualized volatility of 100%, underscoring the risk in the near term.
| Year | Min | Avg | Max | ROI | Sentiment |
|---|---|---|---|---|---|
| $1.45 | $1.85 | $2.63 | 0% | Neutral | |
| $1.34 | $1.84 | $2.74 | 0% | Neutral | |
| $1.15 | $1.68 | $2.66 | -9% | Neutral | |
| $1.13 | $1.74 | $2.90 | -6% | Neutral | |
| $0.9032 | $1.46 | $2.52 | -21% | Bearish | |
| $0.8817 | $1.49 | $2.67 | -20% | Bearish | |
| $1.08 | $1.90 | $3.51 | +3% | Neutral | |
| $1.18 | $2.16 | $4.11 | +17% | Neutral | |
| $1.35 | $2.57 | $5.00 | +39% | Bullish | |
| $1.17 | $2.31 | $4.61 | +25% | Bullish | |
| $1.48 | $3.30 | $7.23 | +78% | Bullish | |
| $2.09 | $4.64 | $10.67 | +151% | Bullish |
Current year — the forecast is anchored to the live price, so ROI shows 0%.
| Month | Min | Avg | Max | Change |
|---|---|---|---|---|
| August 2026 | $1.45 | $1.85 | $2.35 | +0.00% |
| September 2026 | $1.53 | $1.86 | $2.36 | +0.58% |
| October 2026 | $1.56 | $1.92 | $2.49 | +3.35% |
| November 2026 | $1.63 | $2.03 | $2.68 | +5.81% |
| December 2026 | $1.56 | $1.97 | $2.63 | -3.24% |
Click any year to see its month-by-month MNDR forecast. Min / Avg / Max are a bear / base / bull scenario; ROI is the projected move from the current price. Change is the month-over-month move in the average. Estimates, not guarantees.
Expect MNDR to range from $1.45 to $2.63 through 2026. The $1.85 average target implies a 0% move from current prices. Price action looks broadly range-bound.
The MNDR price prediction for 2027 points to an average of $1.84 (low $1.34, high $2.74) — a potential decline of 0% on today's $1.85. A consolidation phase looks the most probable path here.
In 2028, MNDR is projected to trade between $1.15 and $2.66, averaging $1.68 — a potential decline of -9% from today's $1.85. That is -9% versus the projected 2027 average. Price action looks broadly range-bound.
Mobile-health Network Solutions's 2029 outlook centres on $1.74, within a $1.13 to $2.90 range. That is up +4% on the projected 2028 average. That marks a -6% change versus current levels. A consolidation phase looks the most probable path here.
By 2030, MNDR could reach as high as $2.52, with a base case around $1.46 and support toward $0.9032 — roughly -21% from $1.85. A cyclical pullback looks likely — prices rarely move in a straight line.
Expect MNDR to range from $0.8817 to $2.67 through 2031. The $1.49 average target implies a -20% move from current prices. That is up +2% on the projected 2030 average. Expect choppier, lower action through this leg of the cycle.
The MNDR price prediction for 2032 points to an average of $1.90 (low $1.08, high $3.51) — a potential gain of +3% on today's $1.85. Price action looks broadly range-bound.
In 2033, MNDR is projected to trade between $1.18 and $4.11, averaging $2.16 — a potential gain of +17% from today's $1.85. That is up +14% on the projected 2032 average. A consolidation phase looks the most probable path here.
Mobile-health Network Solutions's 2034 outlook centres on $2.57, within a $1.35 to $5.00 range. That is up +19% on the projected 2033 average. That marks a +39% change versus current levels. Momentum favours further upside here.
By 2035, MNDR could reach as high as $4.61, with a base case around $2.31 and support toward $1.17 — roughly +25% from $1.85. Buyers look set to stay in control over this stretch.
Expect MNDR to range from $1.48 to $7.23 through 2040. The $3.30 average target implies a +78% move from current prices. That is up +43% on the projected 2035 average. Momentum favours further upside here.
The MNDR price prediction for 2050 points to an average of $4.64 (low $2.09, high $10.67) — a potential gain of +151% on today's $1.85. Buyers look set to stay in control over this stretch.
Investing $1,000 in MNDR today (≈ 540.540541 MNDR) could be worth
$2,507.12
+$1,507.12 (+151%) by 2050 · US Dollar
Based on the average projected MNDR price of $4.64 in 2050.
Based on the base (average) forecast scenario. FX rates are indicative. Estimates only — not financial advice.
See what a past investment in MNDRwould be worth at today's price.
$1,000 invested in MNDR on Jul 31, 2025 (≈ 206.185571 MNDR) would be worth
$381.44
-$618.56 (-61.9%) today · 0.38× · US Dollar
Based on a MNDR entry price of $4.85 vs. today's $1.85.
| Invested | Entry price | Value today | Return |
|---|---|---|---|
| 1 week ago | $2.18 | $848.62 | -15.1% |
| 1 month ago | $3.24 | $570.99 | -42.9% |
| 3 months ago | $0.95 | $1,947.37 | +94.7% |
| 6 months ago | $1 | $1,850 | +85.0% |
| 1 year ago | $4.85 | $381.44 | -61.9% |
| All time (2.3y) ago | $268 | $6.9 | -99.3% |
Past performance from historical market data — it does not predict future results. FX rates are indicative. Not financial advice.
Enter a price to see how it sits against our MNDR forecast.
Our base-case forecast reaches $3.70 around 2050.
Implied market cap at $3.70: $3.29M
The multi-year forecast shows a shift from neutral/bearish to bullish over the period, with notable upward revisions in the later years. By 2030 the forecast shows an average price of $1.48 and a ROI of -21.1, while 2034 projects an average of $2.61 with a ROI of 38.8, 2040 projects $3.36 with 78.5, and 2050 projects $4.70 with 149.8. This pattern indicates growing long-term upside potential after a weaker early phase.
However, early years also feature flat or negative momentum, and volatility remains high, so outcomes are uncertain.
Tap a question to reveal the answer.
2030: Min $0.9191, Avg $1.48, Max $2.57; ROI -21.1.
The forecast shows neutral to bearish in the near term (e.g., 2026 Avg $1.88; 2027 Avg $1.88; 2030 Avg $1.48 with ROI -21.1), becoming bullish in later years (e.g., 2034 Avg $2.61 with ROI 38.8%; 2050 Avg $4.70 with ROI 149.8%).
By 2040 the average price is projected to $3.36, with 2050 at $4.70; 2034 is $2.61 and 2035 is $2.34.
Current price is $1.88 and market cap is $2.25M.
30-day range is $1.14 to $3.11.
Mobile-health Network Solutions Community Discussion
0Share your Mobile-health Network Solutions price prediction and read what the community thinks. Be respectful — comments are public and not financial advice.
Be the first to share your prediction…
What's your take? Add a comment above to start the conversation.